- Home
- HSCS vs DSS Comparison
HSCS vs DSS Comparison
Compare HSCS & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HSCS | DSS |
|---|---|---|
| Founded | 2007 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Containers/Packaging |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.5M | 9.2M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | HSCS | DSS |
|---|---|---|
| Price | $2.62 | $0.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.20 | N/A |
| AVG Volume (30 Days) | 13.0K | ★ 82.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 42.45 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,085,000.00 |
| Revenue This Year | $1,072.41 | $14.93 |
| Revenue Next Year | $2,700.00 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.01 | $0.72 |
| 52 Week High | $6.47 | $1.90 |
Technical Indicators
Market Signals| Indicator | HSCS | DSS |
|---|---|---|
| Relative Strength Index (RSI) | 34.62 | 43.04 |
| Support Level | $2.16 | $0.88 |
| Resistance Level | $3.28 | $0.99 |
| Average True Range (ATR) | 0.11 | 0.05 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 3.64 | 23.95 |
Price Performance
Historical ComparisonAbout HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.